Go back to Resources
Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute; 5-year follow-up report,
1997
Journal Article
Authors:
Secondary:
J Clin Oncol,
Volume:
15